- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/18 - SulfonesSulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
Patent holdings for IPC class C07C 317/18
Total number of patents in this class: 142
10-year publication summary
7
|
7
|
14
|
12
|
7
|
10
|
6
|
7
|
6
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes Pharma Ireland Limited | 270 |
15 |
PRC-DeSoto International, Inc. | 573 |
8 |
Duke University | 3069 |
5 |
The University of North Carolina at Chapel Hill | 2040 |
5 |
BASF SE | 20940 |
4 |
ProLynx LLC | 51 |
4 |
The University of British Columbia | 1495 |
4 |
Boehringer Ingelheim International GmbH | 4642 |
3 |
Merck Patent GmbH | 5815 |
3 |
Kappa Bioscience AS | 45 |
3 |
Provincial Health Services Authority | 185 |
3 |
Temple University of the Commonwealth System of Higher Education | 621 |
3 |
Translate bio, Inc. | 416 |
3 |
Bristol-myers Squibb Company | 4880 |
2 |
Sumitomo Chemical Company, Limited | 9043 |
2 |
Board of Regents, The University of Texas System | 5808 |
2 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2165 |
2 |
Central Glass Company, Limited | 1264 |
2 |
Dalian University of Technology | 1521 |
2 |
Reviva Pharmaceuticals, Inc. | 45 |
2 |
Other owners | 65 |